Telix Pharmaceuticals Ltd
TLX7.140USD
-0.290-3.90%
Fechamento 02/03, 16:00（ET）Cotações atrasadas em 15 min
0.00Valor de mercado
--P/L TTM
Mais detalhes de Telix Pharmaceuticals Ltd Empresa
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
Informações de Telix Pharmaceuticals Ltd
Código da empresaTLX
Nome da EmpresaTelix Pharmaceuticals Ltd
Data de listagemNov 15, 2017
CEOOrtiz (Raphaeel)
Número de funcionários- -
Tipo de títulosDepository Receipt
Fim do ano fiscal- -
Endereço55 Flemington Road
CidadeMELBOURNE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísAustralia
Código postal3051
Telefone61390933855
Sitehttps://telixpharma.com/
Código da empresaTLX
Data de listagemNov 15, 2017
CEOOrtiz (Raphaeel)
Executivos da empresa Telix Pharmaceuticals Ltd
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Christian P. Behrenbruch, J.D., Ph.D.
Dr. Christian P. Behrenbruch, J.D., Ph.D.
Group Chief Executive Officer, Managing Director, Executive Director
Group Chief Executive Officer, Managing Director, Executive Director
--
--
Dr. Mark Nelson, Ph.D.
Dr. Mark Nelson, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Jann Skinner
Ms. Jann Skinner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. David Cade
Dr. David Cade
Group Chief Medical Officer
Group Chief Medical Officer
--
--
Mr. Richard Valeix
Mr. Richard Valeix
Group Chief Commercial Officer
Group Chief Commercial Officer
--
--
Ms. Tiffany P. Olson
Ms. Tiffany P. Olson
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Darren Smith, CPA
Mr. Darren Smith, CPA
Group Chief Financial Officer
Group Chief Financial Officer
--
--
Mr. Kevin Richardson
Mr. Kevin Richardson
Chief Executive Officer - Telix Precision Medicine
Chief Executive Officer - Telix Precision Medicine
--
--
Mr. Raphaeel Ortiz
Mr. Raphaeel Ortiz
Chief Executive Officer - Telix International
Chief Executive Officer - Telix International
--
--
Ms. Genevieve Ryan
Ms. Genevieve Ryan
Company Secretary
Company Secretary
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Christian P. Behrenbruch, J.D., Ph.D.
Dr. Christian P. Behrenbruch, J.D., Ph.D.
Group Chief Executive Officer, Managing Director, Executive Director
Group Chief Executive Officer, Managing Director, Executive Director
--
--
Dr. Mark Nelson, Ph.D.
Dr. Mark Nelson, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Jann Skinner
Ms. Jann Skinner
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. David Cade
Dr. David Cade
Group Chief Medical Officer
Group Chief Medical Officer
--
--
Mr. Richard Valeix
Mr. Richard Valeix
Group Chief Commercial Officer
Group Chief Commercial Officer
--
--
Ms. Tiffany P. Olson
Ms. Tiffany P. Olson
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Detalhamento da receita
Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: dom, 18 de jan
Atualizado em: dom, 18 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Millennium Management LLC
0.06%
Portland Investment Counsel Inc.
0.04%
Fidelity Management & Research Company LLC
0.04%
Lazard Asset Management, L.L.C.
0.03%
Jane Street Capital, L.L.C.
0.02%
Outro
99.81%
Investidores
Investidores
Proporção
Millennium Management LLC
0.06%
Portland Investment Counsel Inc.
0.04%
Fidelity Management & Research Company LLC
0.04%
Lazard Asset Management, L.L.C.
0.03%
Jane Street Capital, L.L.C.
0.02%
Outro
99.81%
Tipos de investidores
Investidores
Proporção
Investment Advisor
0.11%
Hedge Fund
0.06%
Investment Advisor/Hedge Fund
0.05%
Research Firm
0.02%
Outro
99.76%
Participação acionária institucional
Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
40
844.56K
0.25%
+354.04K
2025Q3
25
456.14K
0.13%
+379.51K
2025Q2
11
269.45K
0.08%
+265.72K
2025Q1
6
20.71K
0.01%
+16.98K
2024Q4
1
3.73K
0.00%
+3.73K
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Millennium Management LLC
196.74K
0.06%
+196.74K
--
Sep 30, 2025
Portland Investment Counsel Inc.
128.00K
0.04%
+128.00K
--
Sep 30, 2025
Fidelity Management & Research Company LLC
118.48K
0.04%
+76.39K
+181.48%
Sep 30, 2025
Lazard Asset Management, L.L.C.
114.62K
0.03%
+114.62K
--
Sep 30, 2025
Jane Street Capital, L.L.C.
72.99K
0.02%
+37.89K
+107.94%
Sep 30, 2025
Marshall Wace LLP
48.57K
0.01%
+48.57K
--
Sep 30, 2025
Private Advisor Group LLC
42.11K
0.01%
+16.95K
+67.33%
Sep 30, 2025
IHT Wealth Management, LLC
26.21K
0.01%
+12.97K
+97.95%
Sep 30, 2025
JPMorgan Private Bank (United States)
25.36K
0.01%
+25.36K
--
Sep 30, 2025
Vanguard Personalized Indexing Management, LLC
18.38K
0.01%
-97.00
-0.53%
Sep 30, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
